SAN
DIEGO, July 30, 2024 /PRNewswire/ -- Heron
Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology
company, today announced that the company will host a conference
call and live webcast on Tuesday, August 6,
2024, at 4:30 p.m. ET to
report second quarter 2024 financial results and discuss recent
business highlights.
The conference call can be accessed by dialing (646) 307-1963 in
the U.S. or (800) 715-9871 internationally. Please provide the
operator with the passcode 1737564 to join the conference call. The
conference call will also be available via webcast under the
Investor Relations section of Heron's website
at www.herontx.com. An archive of the teleconference and
webcast will also be made available on Heron's website for 60 days
following the call.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology
company focused on improving the lives of patients by developing
and commercializing therapeutic innovations that improve medical
care. Our advanced science, patented technologies, and innovative
approach to drug discovery and development have allowed us to
create and commercialize a portfolio of products that aim to
advance the standard-of-care for acute care and oncology patients.
For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These risks
and uncertainties include, but are not limited to, risks and
uncertainties identified in the company's filings with the
Securities and Exchange Commission. Forward-looking statements
reflect our analysis only on their stated date, and Heron takes no
obligation to update or revise these statements except as may be
required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-second-quarter-2024-financial-results-on-tuesday-august-6-2024-302210141.html
SOURCE Heron Therapeutics, Inc.